Summary:
The INSTRIDE Studies are looking to see how well an investigational insulin – designed to be as similar as possible to the diabetes medication insulin glargine (Lantus®) – works to control blood sugar levels.
Qualified Participants Must:
• Be between 18 and 65 years of age
•
Have been diagnosed with Type 2 Diabetes at least a year ago
•
Have been taking Lantus® (insulin glargine) for at least 3 months (you may also be able to take part if you have never taken insulin before).
Qualified Participants May Receive:
Free study related diabetes care and compensation for time and travel.